Granules India informs about company updates

21 Oct 2019 Evaluate

Granules India has informed that the US Food & Drug Administration (US FDA) has approved the Abbreviated New Drug Application (ANDA) filed by the company for Fexofenadine Hydrochloride Tablets USP, 60 mg and 180 mg (OTC). It is bioequivalent to the reference listed drug product (RLD), Allegra Allergy Tablets, 60 mg and 180 mg, of Sanofi-Aventis US LLC. 

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

594.50 -11.40 (-1.88%)
10-Jan-2025 15:12 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1785.90
Dr. Reddys Lab 1354.45
Cipla 1470.90
Lupin 2192.00
Zydus Lifesciences 1005.00
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.